Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024 Jun 22, 2024
Experts recommend structured approach to optimize exercise interventions in MS rehabilitation May 25, 2024
Interpreter access associated with Heart School participation among foreign-born post-heart attack patients May 15, 2024